Abstract:OBJECTIVES:To investigate the relationship between interleukin-8 levels in expressed prostatic secretion and expressions of basic fibroblast growth factor (bFGF) and Bcl-2 in benign prostatic hyperplasia (BPH).METHODS:A series of 50 consecutive patients diagnosed with BPH and scheduled for transurethral resection of the prostate (TURP) were included. Patients were divided into two groups, simple BPH and BPH with chronic prostatitis (CP). The grade of inflammatory changes in the prostate was then determined blindly by two experienced pathologists, according to the classification system. Expressed prostatic secretion (EPS) was collected right before TURP for IL-8 detection using ELISA kits. The resected prostatic tissue was harvested for immunohistochemistry to measure the expression of Bcl-2 and bFGF.RESULTS:A total of 30 (60%) patients were confirmed to have prostatic histologic inflammation. The volume of the prostate in BPH with CP was obviously larger than that in simple BPH (P=0.022). The NIH chronic prostatitis symptom index (NIH-CPSI) and international prostate symptom score (IPSS) of BPH with CP were both higher than those of simple BPH (P<0.05). Significantly increased levels of IL-8 were observed in EPS obtained from BPH patients with CP (mean level, 43.29 ng/L), compared with patients with simple BPH (mean level, 36.90 ng/L) (P=0.003). The expression of Bcl-2 in BPH with CP (mean level, 6.17) increased significantly, compared with those in simple BPH (mean level, 2.45) (P=0.013). The expression of bFGF in BPH with CP (mean level, 7.57) also obviously elevated, compared with those in simple BPH (mean level, 5.05) (P=0.008). Correlation coefficients of IL-8 levels in EPS and expression of Bcl-2 or bFGF indicated that IL-8 had strong correlation with Bcl-2 and bFGF respectively both in simple BPH and BPH with CP (0<R<1, P<0.05).CONCLUSIONS:IL-8, Bcl-2 and bFGF are significantly up-regulated in BPH with CP patients, compared with simple BPH patients. Inflammation might play an important role in the outcome and development of benign prostatic hyperplasia and makes it more severe.

EXPRESSION OF Bcl-2 Mrna IN NORMAL AND HYPERPLASTIC PROSTATE TISSUES

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Change of Nerve Growth Factor Mrna in Human Detrusor in Bladder Outlet Obstruction with Benign Prostatic Hyperplasia and Their Implication

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

Expression of BRG1 and BRM Proteins in Prostatic Cancer

Expressions of Shh and Stathmin in Prostatic Diseases and Their Clinical Significances

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate

Apoptosis Profiles in Benign Prostatic Hyperplasia: Close Associations of Cell Kinetics with Percent Area Density of Histologic Composition.

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

Correlation study on the expression of transforming growth factor-β type I receptor and fibrohlast growth factor type I receptor in BPH

Effect of Hypertension on Cell Proliferation and Apoptosis in Benign Prostatic Hyperplasia

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Expression of Nucleosomal Binding Protein 1 in Normal Prostate Benign Prostate Hyperplasia, and Prostate Cancer and Significance Thereof

Relationship Between Interleukin-8 Levels in Expressed Prostatic Secretion and Expressions of Bfgf and Bcl-2 in Benign Prostatic Hyperplasia

Expression and clinical significance of Bcl-2 in non-small cell lung carcinoma

Effects of macrophage migration inhibitory factor and its receptor CD74 in the development of benign prostatic hyperplasia

Associated study on expression of androgen receptor and type Ⅰ transforming growth factor- β receptor in BPH

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

Differential Transcription of Bcl-2 and Bax Through the Cell Cycle in Prostate Cancer Cell Line